Chinese tech giant Tencent is moving another step further in line with its forays into medtech sector by leading a $40 million USD Series B in online healthcare service Medlinker. FY Capital also participated in the round.

Medlinker is a China-focussed mobile platform that allows physicians to social network and communicate with each other. Doctors on the platform can find contacts of each other and discuss treatment measures for specific cases. In its latest update, the app added a WeChat-like group-chat feature to facilitate communication among users. While the concept of private tech companies facilitating basic medical services may seem foreign in other countries, China’s health system is often critically underfunded and disjointed.

Medlink users have to register with their real name to ensure the professionality of the platform. Personal information like contacts, hospitals they are working in and job titles are required in the registration process.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Emma Lee

Emma Lee is Shanghai-based tech writer, covering startups and tech happenings in China and Asia in general. We are looking for stories related to tech and China. Reach her at lixin@technode.com.